Equities
  • Price (SEK)24.56
  • Today's Change0.02 / 0.08%
  • Shares traded638.52k
  • 1 Year change+2.33%
  • Beta1.0440
Data delayed at least 15 minutes, as of Jan 21 2022 17:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Cloetta AB is a Sweden-based company active in the chocolate and sugar confectionery market. The primary ingredient for its products is cocoa. The Company uses cocoa mass that is produced from seeds found in the fruit of cocoa trees grown along the equator. It produce and sells products within three main categories, namely Chocolate, which comprises chocolate wafers, plates, pralines and dragees; Sugar confectionery, which comprises foam, wine gums, liquorice, toffees, hard boiled candy, chewy candy, toffee/fudge/caramel and lollypops, and Refreshment, which comprises pastilles and chewing gum. The Company owns such brands, as Lakerol, Cloetta, Jenkki, Kexchoklad, Malaco, Sportlife, Saila, Red Band and Sperlari. The Company has 12 production units in six countries. In January 2014, it acquired Alrifai Nutisal AB. In May 2014, it acquired 75% of shares of Aran Candy Ltd and the brand The Jelly Bean Factory, Irish company producing and selling gourmet Jelly Beans.

  • Revenue in SEK (TTM)5.85bn
  • Net income in SEK429.00m
  • Incorporated--
  • Employees2.60k
  • Location
    Cloetta ABSodra Forstadsgatan 34MALMO 211 43SwedenSWE
  • Phone+46 40324200
  • Fax+46 40324150
  • Websitehttps://www.cloetta.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
HKScan Corporation18.74bn34.42m1.59bn6.96k37.130.52012.180.08490.04390.043923.203.131.8912.5114.02266,503.500.9599-2.811.51-4.207.1530.340.5065-1.450.39392.130.5132--2.10-1.4698.10--10.30-26.52
Atria Oyj16.01bn-107.28m2.25bn3.69k--0.71884.360.1408-0.3605-0.360554.5115.781.6612.7312.11345,440.20-0.93272.36-1.323.4111.8211.41-0.56231.490.604350.240.294865.253.642.3351.9010.68-4.054.56
Hofseth Biocare ASA87.30m-124.20m2.31bn49.00--12.66--26.48-0.3391-0.33910.23830.49440.22970.70199.141,726,306.00-32.67-38.24-50.71-58.0936.3320.26-142.27-154.830.7898-14.160.443--2.174.66-14.43--35.69--
Midsona AB3.84bn143.00m2.90bn819.0018.401.019.690.75362.162.1658.1939.300.7594.0010.124,609,113.002.823.073.393.6227.8930.603.723.920.72254.200.332261.1520.3825.8781.4421.6796.558.04
Aker Biomarine ASA2.41bn31.02m4.16bn549.0080.421.197.771.730.57270.572729.8638.580.35951.244.064,246,084.000.4634-2.220.5167-2.5536.0149.091.29-5.391.24--0.4613--17.2322.8477.00--6.24--
Raisio Oyj2.50bn233.65m5.51bn381.0022.191.8517.502.200.14450.14451.561.730.74034.817.07702,046.806.915.847.667.0425.4128.699.338.753.26--0.0929107.66-1.14-14.83-8.24-7.7412.91-4.07
Cloetta AB5.85bn429.00m6.95bn2.60k16.461.609.981.191.491.4920.3515.400.60894.075.962,205,051.004.473.946.215.2535.6637.057.336.300.9253--0.356662.51-12.290.0598-43.57-6.1512.498.45
Norway Royal Salmon ASA5.63bn424.33m7.90bn217.0018.452.0712.891.409.529.52126.3584.730.79332.6215.5025,159,170.006.6411.808.5515.2717.6218.528.379.780.378--0.338851.86-8.379.78-82.12-18.9946.11-4.15
BioGaia AB766.56m196.47m9.54bn159.0050.015.3942.5712.459.819.8138.3491.050.5722----4,790,981.0014.6625.7015.9130.5073.5673.9125.6327.04--371.010.0061.63-2.779.10-4.075.50-10.46-7.37
Schouw & Co A/S32.03bn1.42bn19.98bn9.98k13.321.317.640.623741.9841.98949.08426.951.174.625.022,433,302.005.176.308.119.0616.2116.474.435.250.790222.390.234734.751.5611.100.10987.083.816.96
Austevoll Seafood ASA26.15bn1.46bn23.68bn6.34k16.141.795.750.90567.017.01125.4063.300.61332.0211.213,995,539.005.857.079.7611.9641.9546.389.5411.831.59--0.312357.46-3.768.04-60.67-7.316.31-12.94
Data as of Jan 21 2022. Currency figures normalised to Cloetta AB's reporting currency: Swedish Krona SEK

Institutional shareholders

24.19%Per cent of shares held by top holders
HolderShares% Held
Wellington Management International Ltd.as of 31 Dec 202013.88m4.91%
Financi�re de l'�chiquier SAas of 31 Dec 20209.41m3.33%
Franklin Templeton Institutional LLCas of 31 Dec 20208.65m3.06%
Dimensional Fund Advisors LPas of 06 Jan 20228.32m2.94%
Nordea Investment Management ABas of 30 Nov 20217.01m2.48%
Norges Bank Investment Managementas of 31 Dec 20205.34m1.89%
The Vanguard Group, Inc.as of 06 Jan 20225.13m1.82%
Ohio Police & Fire Pension Fundas of 31 Dec 20203.79m1.34%
Polaris Capital Management LLCas of 31 Dec 20213.73m1.32%
BlackRock Fund Advisorsas of 06 Jan 20223.15m1.11%
More ▼
Data from 31 Dec 2020 - 31 Dec 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.